ABSTRACT We have analyzed the RNA produced in vitro by incubating nuclei from HeLa cells infectedwith adenovirus serotype 2. Our results show that adenovirus-specific RNA is produced at a linear rate for up to 2.5 hr. Hybridization analysis of RNA produced in nuclei isolated 18 hr after infection indicated that transcription begins at the "late promoter" at map position 16.5. Sequence analysis of the 5 termini of the in vitro transcripts showed that this system initiates RNA chains de novo at the correct promoter and that the 5' terminus is capped. The process of regulation of gene expression at the level of RNA transcription is reasonably well understood in prokaryotic systems. The enzymes involved in mRNA synthesis and the factors that regulate these enzymes have been well studied (1). These findings have in large part been due to the availability of in vitro systems capable of synthesizing mRNA. In contrast, little is known about the biochemistry of these processes in eukaryotic systems. It is well established that in eukaryotes there are distinct RNA polymerases that catalyze the synthesis of ribosomal RNA (RNA polymerase I), mRNA (RNA polymerase II), and tRNA and 5S RNA (RNA polymerase III) (2). To date, however, there have been no reports demonstrating the synthesis of mRNA, or its precursor, in vitro.
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In an attempt to gain insight into the biochemical mechanisms involved in mRNA biosynthesis, systems containing isolated nuclei from mammalian cells have been used (3, 4) . It has been reported that initiation of RNA chains dependent upon RNA polymerase II can take place in isolated nuclei (5) . Other recent results have suggested that large nuclear transcripts are generated de novo in isolated nuclei (6).
In order to clarify the nature of the transcription observed in isolated nuclei, we turned our attention to the activity of nuclei isolated from cells during the late phase of infection by adenovirus serotype 2 (Ad2). This system has many advantages over systems from uninfected cells. Both RNA polymerase II and RNA polymerase III catalyze the synthesis of viral specific RNA in these nuclei, and the in vivo strand specificity of transcription is retained (7-10). The product of RNA polymerase III activity on viral DNA is two small defined RNAs (VA RNAs) and this polymerase will initiate transcription of these small RNAs upon incubation of nuclei extracted from late infected cells (11). The RNA polymerase II transcription units in these cells have also been defined. Specifically, the origin of the transcription unit leading to the synthesis of the majority of late mRNAs has been localized by various methods (12) (13) (14) (15) , all of which place the site for initiation of transcription at approximately 16.5% on the Ad2 genome. In keeping with these results is the finding of a unique 5'-end sequence on most, if not all, late viral cytoplasmic mRNAs (16). This undecanucleotide contains a 7-methylguanosine "cap" and has been identified on the 5' end of two purified mRNAs as well as of nuclear pre-mRNA (17, 18). The DNA sequence encoding this undecanucleotide has recently been localized in the adenovirus genome, thereby confirming the assignment of the 16.5% location as a "promoter" site for late transcription (18) .
In this report, we demonstrate that nuclei isolated from Ad2-infected cells 18 hr after infection are capable of supporting initiation of transcription. The in vitro transcript begins at the promoter for the major late transcription unit, and it contains the capped 5'-undecanucleotide.
MATERIALS AND METHODS Cells, Virus, and DNA. HeLa cells were propagated in suspension culture in Eagle's minimal essential medium supplemented with 5% horse serum. Cells at a concentration of 4-6 X 105 cells per ml were infected with Ad2 (25 plaque-forming units per cell). Infections were carried out by adsorbing the virus to the cells after concentration to 4-6 X 106 cells per ml. After a 1-hr incubation at 37"C, the cells were diluted to 4 X 105/ml with fresh medium. For preparation of nuclei, cells were harvested 18 hr after infection. DNA was extracted from purified virions as described (19) . DNA was digested with BamHI, and the DNA fragments were separated and recovered as described (20 Analysis of Oligonucleotides by Dihydroxyboryl Cellulose Chromatography. RNA digested with RNase T1 was phenol extracted, ether extracted, and adjusted to 0.6 M KCl, 0.05 M N-methylmorpholine (pH 8.5), and 20% ethanol. The RNA was then bound to a column of dihydroxyboryl cellulose and eluted, concentrated, and desalted as described (16). The oligonucleotides were fractionated by two-dimensional fingerprint analysis, using homomixture C in the second dimension (26) . that favor DNA-RNA hybrid formation and treated with nuclease Si, and then the resistant hybrids are analyzed by agarose gel electrophoresis.
RESULTS

Properties
Radioactive RNA was hybridized to BamHI fragment B (0-29.1 map units), treated with nuclease Si, and analyzed by gel electrophoresis (Fig. 2) . The length of the major protected fragment (12.5% of Ad2 length) is consistent with the 5' end point of the-transcripts being at position 16.5 (29.1-12.5). The assignment of the exact location was made by using overlapping DNA restriction fragments. In addition to the DNA-RNA hybrid of approximately 12.5%, we reproducibly observed a hybrid of 9.5% of the genome length, the 5' end point of which is located at map position 19.5.
The amount of RNA recovered in a hybrid with BamHI fragment B was approximately equimolar with. the amount hybridizing to fragments extending toward 100%, as judged by -Pf6c. Nati. Acad. Sci. USA 76-(1979) -'position of ATP or GTP into polynucleotide is an accepted way of demonstrating de novo initiation (II). However, a triphosphorylated-terminated RNA synthesized by RNA polymerase II has not yet been documented, nor has a known mRNA-like transcript been isolated containing a triphosphorylated terminus. Therefore, we attempted to demonstrate the incorporation of radioactivity in vitro into the capped undecanucleotide found on the 5' end of Ad2 late mRNAs (16, 17). This oligonucleotide is encoded in the DNA sequence at position 16.5 (18) . To this end, total nuclear RNA (labeled in vitro) was hydrolyzed with RNase T1, fractionated on a column of dihydroxyboryl cellulose, and analyzed by fingerprinting.
A fingerprint of total RNA synthesized in the in vitro system using [a-32P]GTP is shown in Fig. 3A . A much simpler fingerprint was given by the oligonucleotides eluted from dihy- We used this hybridization technique to obtain evidence for in vitro initiation of transcription at position 16.5. Molecules just initiated in vivo and then elongated in vitro to a length greater than approximately 4 kb will give rise to the DNA-RNA hybrid band shown in Fig. 2 . The chain elongation rate measured in this system was approximately 400-500 nucleotides per minute, as determined by measuring the rate of accumulation of "fully dense" RNA when Hg UTP is used as a precursor (6). Thus, labeling for 20 min should allow all molecules previously initiated to grow to lengths greater than 4 kb. If we allow elongation to proceed for 20 min in the presence of nonradioactive precursors and then add a-32P-labeled UTP for 20 min, radioactive molecules hybridizing to the segment 16.5-29.1 should be ones that are either elongating slowly or have initiated in vitro. This analysis was extended to labeled RNAs made during 20-min intervals for up to 120 min. Fig. 2 shows that radioactive molecules with 5' ends at position 16.5 were synthesized throughout the 120-min incubation period. These results strongly suggest that the nuclei in this system are supporting in vitro chain initiation. However, to rule out the possibility that there is a large pool of "preinitiated" chains that are simply being elongated in vitro, we analyzed the radioactivity incorporated into the first 11 nucleotides of the tran- (120 Ci/mmol), and those in D were from one containing 600 MACi of [a-32P]CTP (120 Ci/mmol). After 2-hr incubation in vitro, nuclei were pelleted and RNA was extracted. RNA was digested with RNase T1 and selected on columns of dihydroxyboryl cellulose. Approximately 0.8% of the radioactivity applied to the columns was bound and eluted. The oligonucleotides were then purified and displayed by fingerprint analysis as described (16, 26) . A shows the fingerprint of an aliquot (0.5%) of the RNA prior to selection on dihydroxyboryl cellulose. All spots in B, C, and D that migrated slower than the yellow dye (spot of radioactive ink) in the second dimension were eluted and digested with RNase T2. The only spot in each fingerprint with detectable levels of T2-resistant radioactivity is indicated by an arrow. droxyboryl cellulose (Fig. 3B) . All spots migrating slower than the yellow dye in the second dimension were eluted and digested with RNase T2. Only the spot indicated by the arrow (Fig. 3B) reproducibly contained an oligonucleotide partially resistant to T2 (Fig. 4, track 1 ). This oligonucleotide yielded m7GMP when it was digested with snake venom phosphodiesterase (not shown). An additional spot, that also yielded a low level of a T2-resistant radioactivity and migrated slightly faster in the first dimension than the spot marked by the arrow, has occasionally been detected (Fig. 3 C and D ; the spot immediately to the left of the one indicated by the arrow). This observation is consistent with previous findings (16) and has not been investigated further. From the known composition of the undecanucleotide (16), we expected that both the Tl-resistant oligonucleotide and the T2-resistant structure generated from it could also be labeled with CTP or UTP. In fact, the spots marked with arrows in Fig. 3C and C also contained the T2-resistant oligonucleotide (Fig. 4, tracks 3 and 4) . In addition to the resistant oligonucleotides shown in Fig. 4 , larger than expected amounts of radioactivity can be detected as mononucleotides. In order to quantitate the relative amounts of radioactivity in the cap and mononucleotides, the T1 spots therefore had to be repurified prior to RNase T2 digestion.
To this end, we isolated the oligonucleotide labeled with CTP from a two-dimensional fingerprint and incubated it with RNase U2. Because the only A residue present in the undecanucleotide is 2'-O-methylated and therefore resistant to RNase U2, the Tl-resistant oligonucleotide we isolated should be completely resistant to RNase U2. Fig. 4 (track 5) demonstrates the presence of a U2-resistant undecanucleotide. show RNase T2 digests analyzed by electrophoresis at pH 3.5 on DEAE paper. Track 5 shows a RNase U2 digestion, analyzed by homochromatography on a DEAE-cellulose thin layer. The oligonucleotides analyzed were as follows: track 1, spot indicated by arrow in Fig. 3B ; track 2, typical spot from the fingerprint shown in Fig. 3B ; track 3, spot indicated by arrow in Fig. 3C ; track 4, spot indicated by arrow in Fig. 3D ; and track 5, T1 oligonucleotide of Table 2 . 0, origin in each case; B and Y, positions to which the blue and yellow dyes migrated during homochromatography. The radioactive spots with greatest mobility in tracks 1-4 are pU, preceded by pC and then pA and pG, which are not separated by the electrophoretic conditions used. The T2-resistant structure barely migrated from the origin. Knowing the sequence of the undecanucleotide, m7Gppp*AmC-U-C-U-C-U-U-C-C-G-(Q (ref. 18 ; R. Lockard, personal communication), the nearest-neighbor results can be predicted. The repurified material was therefore digested with RNase T2 and the products were resolved on DEAE paper. Table 2 presents the nearest-neighbor analysis obtained, which is in excellent agreement with the predicted values. In addition, digestion of the CTP-labeled T2-resistant moiety with nuclease P1 yielded exclusively pC, proving that the second nucleotide from the 5'-terminal m7G is C (data not shown). Thus we conclude that radioactivity is incorporated into the second nucleotide and then the next nine nucleotides of the in vitro transcripts and that this corresponds exactly to the 5' end detected in vivo.
By quantitating the amount of radioactivity derived from CTP incorporated into the.undecanucleotide relative to the amount incorporated into the total RNA transcript, we can determine the number of chains initiated: 52% of the in vitro transcription is Ad2 specific (Table 1) , all (>90%) of this transcription is from the 25-kb major late transcription unit (14, 15), and the RNA transcript is 28% C (27). From these numbers we calculate that the theoretical yield of the capped undecanucleotide should be 0.045% of the total radioactivity incorporated, if all the transcription observed is into chains intiated in vitro. After correcting for losses [the major one being an estimated 30% recovery on the dihydroxyboryl cellulose column (17)], we found, in the experiment described in Table 2 , that 0.0052% (6.3 X 102 cpm/1.2 X 108 cpm) of the radioactivity incorporated into RNA was in the purified undecanucleotide. Therefore we estimate that at least 12% of the observed transcription is onto chains initiated at the correct promoter in vitro. Because our assay detects only transcripts that have been capped and methylated correctly, as well as initiated, this number may be an underestimate.
DISCUSSION
We have presented evidence that nuclei prepared from cells infected with Ad2 are capable of supporting RNA chain initiation in vitro at the major late promoter. Furthermore, this RNA is capped and methylated correctly. Only a cap 1 structure (m7Gppp*AmpCp) is produced by the isolated nuclei (Fig. 4) 4 0 cap I to cap 2 is a cytoplasmic reaction and therefore does not _-Wethank E. Ziff, R. C. C. Huang, and R. Lockard for communioccur in isolated nuclei. This has in fact been shown to be the c---cating their results prior to publication and S. Huang for excellent case in the synthesis of L cell mRNA cap structures (28 
